Drugs / Succinic Acid
last change Sep 2024 re-read 9 days ago

Succinic Acid

Small molecule

Developed for
brain injury
Investigated by
POLYSAN Scientific & Technological Pharmaceutical Company

Trials 1

202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT04631484 Nov 2020 → May 2024 brain injury POLYSAN Scientific & Technological Pharmaceutical Company Completed Met primary

Evidence & citations 8 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as Succinic Acid ClinicalTrials.gov intervention name — accepted as the source's own label NCT04631484 ↗
Known as Amber acid ChEMBL registry synonym — accepted as the source's own label CHEMBL576 ↗
Known as Dihydrofumaric acid ChEMBL registry synonym — accepted as the source's own label CHEMBL576 ↗
Known as E363 ChEMBL registry synonym — accepted as the source's own label CHEMBL576 ↗
Known as FEMA NO. 4719 ChEMBL registry synonym — accepted as the source's own label CHEMBL576 ↗
Known as NSC-106449 ChEMBL registry synonym — accepted as the source's own label CHEMBL576 ↗
Known as Succinicum acidum ChEMBL registry synonym — accepted as the source's own label CHEMBL576 ↗
Modality Small molecule — CHEMBL576 ↗